LORazepam 2 MG/ML, 1 ML Inj (Ativan inj)

LORazepam 2 MG/ML, 1 ML Inj (Ativan inj)

Advisories: REQUIRED ALL INSTITUTIONS STOCK INJECTABLE LORAZEPAM, INJECTABLE BENZTROPINE , AND INJECTABLE IMMEDIATE RELEASE HALOPERIDOL & THAT IT BE ACCESSIBLE FOR PSYCHIATRIC EMERGENCIES Non-Formulary Use Criteria: 01. Control of severe agitation in psychiatric patients 02. When lack of sleep causes an exacerbation of psychiatric illness. 03. Part of a prolonged taper schedule 04. Detoxification for substance abuse 05. Failure of standard modalities for seizure disorders ( 4th line therapy) 06. Long-term use for terminally ill patients for palliative care ( e.g. hospice patients) 07. Adjunct to neuroleptic therapy to stabilize psychosis. 08. Second line therapy for anti-mania. 09. Psychotic syndromes presenting with catatonia ( refer to BOP Schizophrenia Clinical Practice Guideline) 10. Akathisia which is non-responsive to beta blocker at maximum dose or unsuccessful conversion to another antipsychotic agent 11. Nausea and Vomiting in Oncology Treatment patients Formulary Restrictions: Formulary for 30 days only. Is this order for less than 31 days? MLP Requires Cosign

Dr. M Blatstein

Comments are closed.
YouTube
YouTube
LinkedIn
LinkedIn
Share